Literature DB >> 3791195

Radiation sensitivity in vitro of cells isolated from human tumor surgical specimens.

E K Rofstad, A Wahl, T Brustad.   

Abstract

The radiation sensitivity of cells isolated directly from human tumor surgical specimens was studied using the Courtenay soft agar colony assay. Aerobic cell survival curves covering 2-3 decades were achieved for eight melanomas, seven ovarian, six cervix, five breast, four bladder, and four squamous cell carcinomas of the head and neck and two seminomas. Cell survival following exposure to 2.0 Gy was measured also for several other tumors of these histological types. Experiments repeated with cells stored in liquid nitrogen showed that the survival assay gave highly reproducible results. The D0 (0.61-1.65 Gy) as well as the surviving fraction at 2.0 Gy (0.12-0.66) differed considerably among individual tumors of the same histological type. Neither of these parameters was therefore significantly different for the seven tumor categories. However, about one-third of the melanomas showed a higher surviving fraction at 2.0 Gy than the highest value measured for the other tumors. Two of three seminomas showed surviving fractions at 2.0 Gy in the absolute lower range, i.e., below 0.20. Altogether the data were consistent with the suggestion recently put forward that the clinical radiocurability of tumors may be correlated to the cell surviving fraction in vitro at 2.0 Gy. However, it was not possible on the basis of individual tumors to investigate whether the surviving fraction at 2.0 Gy was correlated to the clinical radiocurability, since adequate clinical data were not available for the parent tumors. It is suggested that melanomas may be especially suitable for prospective studies aimed at establishing whether such a correlation really does exist. If a significant correlation can be verified, then a very important conclusion may be drawn from our data: the radiocurability of human tumors may differ almost just as much among individual tumors of the same histological type as among individual tumors of different histology.

Entities:  

Mesh:

Year:  1987        PMID: 3791195

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.

Authors:  F M Uckun; W Jaszcz; M Chandan-Langlie; K G Waddick; K Gajl-Peczalska; C W Song
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

2.  Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy?

Authors:  Steven E Schild; Deepti Behl; Svetomir N Markovic; Paul D Brown; Jonathan R Sande; Richard L Deming; Kendrith M Rowland; James D Bearden
Journal:  Am J Clin Oncol       Date:  2010-12       Impact factor: 2.339

3.  Palliative radiotherapy for Japanese patients with malignant melanoma: a single-institution experience.

Authors:  Keiichiro Koiwai; Shigeru Sasaki; Eriko Yoshizawa; Hironobu Ina; Ayumu Fukazawa; Katsuya Sakai; Takesumi Ozawa; Hirohide Matsushita; Masumi Kadoya
Journal:  Jpn J Radiol       Date:  2015-12-14       Impact factor: 2.374

4.  Malignant melanoma and radiotherapy: past myths, excellent local control in 146 studied lesions at Georgetown University, and improving future management.

Authors:  Pooya Jahanshahi; Nadim Nasr; Keith Unger; Ali Batouli; Gregory J Gagnon
Journal:  Front Oncol       Date:  2012-11-15       Impact factor: 6.244

5.  Adjuvant radiation therapy in metastatic lymph nodes from melanoma.

Authors:  Jean-Emmanuel Bibault; Sylvain Dewas; Xavier Mirabel; Laurent Mortier; Nicolas Penel; Luc Vanseymortier; Eric Lartigau
Journal:  Radiat Oncol       Date:  2011-02-06       Impact factor: 3.481

6.  The in vitro radiosensitivity of human head and neck cancers.

Authors:  T Björk-Eriksson; C M West; E Karlsson; N J Slevin; S E Davidson; R D James; C Mercke
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

7.  Heat sensitivity and thermotolerance in vitro of human breast carcinoma, malignant melanoma and squamous cell carcinoma of the head and neck.

Authors:  E K Rofstad
Journal:  Br J Cancer       Date:  1990-01       Impact factor: 7.640

8.  Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern.

Authors:  E K Rofstad
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

Review 9.  Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.

Authors:  Amy J C Dohmen; Justin E Swartz; Michiel W M Van Den Brekel; Stefan M Willems; René Spijker; Jacques Neefjes; Charlotte L Zuur
Journal:  Cancers (Basel)       Date:  2015-08-28       Impact factor: 6.639

10.  Definitive Radiotherapy With SBRT or IMRT Boost for Breast Cancer: Excellent Local Control and Cosmetic Outcome.

Authors:  Yuta Shibamoto; Taro Murai; Kazushi Suzuki; Chisa Hashizume; Kengo Ohta; Yuki Yamada; Masanari Niwa; Akira Torii; Masashi Shimohira
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.